1 line
No EOL
24 KiB
Text
1 line
No EOL
24 KiB
Text
{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T19:02:55Z","timestamp":1705604575607},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n <jats:title>Purpose<\/jats:title>\n <jats:p>The OsteoCool Tumor Ablation Post-Market Study (OPuS One) was a prospective, multi-national, single-arm study to investigate safety and effectiveness of radiofrequency ablation (RFA) for palliation of painful lytic bone metastases with 12\u00a0months of follow-up. RFA has demonstrated effective palliation of osseous metastases in small clinical studies with short-term follow-up; however, a long-term assessment with robust subject numbers is lacking.<\/jats:p>\n <\/jats:sec><jats:sec>\n <jats:title>Materials and Methods<\/jats:title>\n <jats:p>Prospective assessments were conducted at Baseline, 3\u00a0days, 1\u00a0week, and 1, 3, 6, and 12-months. Pain and quality of life were measured prior to RFA and postoperatively using the Brief Pain Inventory, European Quality of Life\u20145 Dimension, and European Organization for Research and Treatment of Cancer Care Quality of Life Questionnaire for palliative care. Radiation, chemotherapy and opioid usage, and related adverse events were collected.<\/jats:p>\n <\/jats:sec><jats:sec>\n <jats:title>Results<\/jats:title>\n <jats:p>206 subjects were treated with RFA at 15 institutions in OPuS One. Worst pain, average pain, pain interference and quality of life significantly improved at all visits starting 3\u00a0days post-RFA and sustained to 12\u00a0months (<jats:italic>P<\/jats:italic>\u2009<\u20090.0001). Post hoc analysis found neither systemic chemotherapy nor local radiation therapy at the index site of RFA influenced worst pain, average pain, or pain interference. Six subjects had device\/procedure-related adverse events.<\/jats:p>\n <\/jats:sec><jats:sec>\n <jats:title>Conclusion<\/jats:title>\n <jats:p>RFA for lytic metastases provides rapid (within 3\u00a0days) and statistically significant pain and quality of life improvements with sustained long-term relief through 12\u00a0months and a high degree of safety, independent of radiation.<\/jats:p>\n <\/jats:sec><jats:sec>\n <jats:title>Level of Evidence: 2b, Prospective, Non-Randomized, Post-Market study<\/jats:title>\n <jats:p>This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.springer.com\/00266\">www.springer.com\/00266<\/jats:ext-link>.<\/jats:p>\n <\/jats:sec>","DOI":"10.1007\/s00270-023-03417-x","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T19:02:41Z","timestamp":1680548561000},"page":"600-609","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Radiofrequency Ablation Provides Rapid and Durable Pain Relief for the Palliative Treatment of Lytic Bone Metastases Independent of Radiation Therapy: Final Results from the OsteoCool Tumor Ablation Post-Market Study"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"http:\/\/orcid.org\/0000-0002-1272-5530","authenticated-orcid":false,"given":"Jason","family":"Levy","sequence":"first","affiliation":[]},{"given":"Elizabeth","family":"David","sequence":"additional","affiliation":[]},{"given":"Thomas","family":"Hopkins","sequence":"additional","affiliation":[]},{"given":"Jonathan","family":"Morris","sequence":"additional","affiliation":[]},{"given":"Nam D.","family":"Tran","sequence":"additional","affiliation":[]},{"given":"Hamed","family":"Farid","sequence":"additional","affiliation":[]},{"given":"Francesco","family":"Massari","sequence":"additional","affiliation":[]},{"given":"William G.","family":"O\u2019Connell","sequence":"additional","affiliation":[]},{"given":"Alexander","family":"Vogel","sequence":"additional","affiliation":[]},{"given":"Afshin","family":"Gangi","sequence":"additional","affiliation":[]},{"given":"Peter","family":"Sunenshine","sequence":"additional","affiliation":[]},{"given":"Robert","family":"Dixon","sequence":"additional","affiliation":[]},{"given":"Nicolas","family":"Von der H\u00f6h","sequence":"additional","affiliation":[]},{"given":"Sandeep","family":"Bagla","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,4,3]]},"reference":[{"issue":"6","key":"3417_CR1","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1093\/annonc\/mdi191","volume":"16","author":"CS Cleeland","year":"2005","unstructured":"Cleeland CS, Portenoy RK, Rue M, et al. Does an oral analgesic protocol improve pain control for patients with cancer? An intergroup study coordinated by the Eastern Cooperative Oncology Group. Ann Oncol. 2005;16(6):972\u201380. https:\/\/doi.org\/10.1093\/annonc\/mdi191.","journal-title":"Ann Oncol"},{"key":"3417_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ejca.2016.10.021","volume":"71","author":"R von Moos","year":"2017","unstructured":"von Moos R, Costa L, Ripamonti CI, Niepel D, Santini D. Improving quality of life in patients with advanced cancer: Targeting metastatic bone pain. Eur J Cancer. 2017;71:80\u201394. https:\/\/doi.org\/10.1016\/j.ejca.2016.10.021.","journal-title":"Eur J Cancer"},{"issue":"5","key":"3417_CR3","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1016\/j.ijrobp.2011.02.008","volume":"82","author":"E Chow","year":"2012","unstructured":"Chow E, Hoskin P, Mitera G, et al. Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Int J Radiat Oncol Biol Phys. 2012;82(5):1730\u20137. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.02.008.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3417_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1748-717X-9-69","volume":"9","author":"CG Fisher","year":"2014","unstructured":"Fisher CG, Schouten R, Versteeg AL, et al. Reliability of the Spinal Instability Neoplastic Score (SINS) among radiation oncologists: an assessment of instability secondary to spinal metastases. Radiat Oncol. 2014;9:69. https:\/\/doi.org\/10.1186\/1748-717X-9-69.","journal-title":"Radiat Oncol"},{"issue":"3","key":"3417_CR5","doi-asserted-by":"publisher","first-page":"e343","DOI":"10.1016\/j.ijrobp.2012.04.034","volume":"84","author":"MV Cunha","year":"2012","unstructured":"Cunha MV, Al-Omair A, Atenafu EG, et al. Vertebral compression fracture (VCF) after spine stereotactic body radiation therapy (SBRT): analysis of predictive factors. Int J Radiat Oncol Biol Phys. 2012;84(3):e343\u2013e349. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.04.034.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"3417_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.4081\/oncol.2017.321","volume":"11","author":"F Macedo","year":"2017","unstructured":"Macedo F, Ladeira K, Pinho F, et al. Bone metastases: An overview. Oncol Rev. 2017;11(1):321. https:\/\/doi.org\/10.4081\/oncol.2017.321.","journal-title":"Oncol Rev"},{"issue":"9","key":"3417_CR7","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s00270-016-1400-8","volume":"39","author":"S Bagla","year":"2016","unstructured":"Bagla S, Sayed D, Smirniotopoulos J, et al. Multicenter prospective clinical series evaluating radiofrequency ablation in the treatment of painful spine metastases. Cardiovasc Intervent Radiol. 2016;39(9):1289\u201397. https:\/\/doi.org\/10.1007\/s00270-016-1400-8.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"4","key":"3417_CR8","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/cncr.24837","volume":"116","author":"DE Dupuy","year":"2010","unstructured":"Dupuy DE, Liu D, Hartfeil D, et al. Percutaneous radiofrequency ablation of painful osseous metastases: a multicenter American College of Radiology Imaging Network trial. Cancer. 2010;116(4):989\u201397. https:\/\/doi.org\/10.1002\/cncr.24837.","journal-title":"Cancer"},{"issue":"2","key":"3417_CR9","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1200\/JCO.2004.03.097","volume":"22","author":"MP Goetz","year":"2004","unstructured":"Goetz MP, Callstrom MR, Charboneau JW, et al. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol. 2004;22(2):300\u20136. https:\/\/doi.org\/10.1200\/JCO.2004.03.097.","journal-title":"J Clin Oncol"},{"issue":"7","key":"3417_CR10","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s00270-018-1944-x","volume":"41","author":"N Tanigawa","year":"2018","unstructured":"Tanigawa N, Arai Y, Yamakado K, et al. Phase I\/II Study of Radiofrequency Ablation for Painful Bone Metastases: Japan Interventional Radiology in Oncology Study Group 0208. Cardiovasc Intervent Radiol. 2018;41(7):1043\u20138. https:\/\/doi.org\/10.1007\/s00270-018-1944-x.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"11","key":"3417_CR11","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/j.jvir.2020.07.014","volume":"31","author":"J Levy","year":"2020","unstructured":"Levy J, Hopkins T, Morris J, et al. radiofrequency ablation for the palliative treatment of bone metastases: outcomes from the multicenter osteocool tumor ablation post-market study (OPuS One Study) in 100 patients. J Vasc Interv Radiol. 2020;31(11):1745\u201352. https:\/\/doi.org\/10.1016\/j.jvir.2020.07.014.","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"3417_CR12","doi-asserted-by":"publisher","first-page":"M139","DOI":"10.1093\/geronj\/46.4.m139","volume":"46","author":"V Crooks","year":"1991","unstructured":"Crooks V, Waller S, Smith T, Hahn TJ. The use of the Karnofsky Performance Scale in determining outcomes and risk in geriatric outpatients. J Gerontol. 1991;46(4):M139-144. https:\/\/doi.org\/10.1093\/geronj\/46.4.m139.","journal-title":"J Gerontol"},{"issue":"20 Pt 2","key":"3417_CR13","doi-asserted-by":"publisher","first-page":"6236s","DOI":"10.1158\/1078-0432.CCR-06-0988","volume":"12","author":"CS Cleeland","year":"2006","unstructured":"Cleeland CS. The measurement of pain from metastatic bone disease: capturing the patient\u2019s experience. Clin Cancer Res. 2006;12(20 Pt 2):6236s\u201342s. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-0988.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"3417_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.suponc.2010.12.004","volume":"9","author":"SD Mathias","year":"2011","unstructured":"Mathias SD, Crosby RD, Qian Y, Jiang Q, Dansey R, Chung K. Estimating minimally important differences for the worst pain rating of the Brief Pain Inventory-Short Form. J Support Oncol. 2011;9(2):72\u20138. https:\/\/doi.org\/10.1016\/j.suponc.2010.12.004.","journal-title":"J Support Oncol"},{"issue":"3","key":"3417_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"G EuroQol","year":"1990","unstructured":"EuroQol G. EuroQol\u2013-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199\u2013208. https:\/\/doi.org\/10.1016\/0168-8510(90)90421-9.","journal-title":"Health Policy"},{"issue":"1","key":"3417_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejca.2005.06.022","volume":"42","author":"M Groenvold","year":"2006","unstructured":"Groenvold M, Petersen MA, Aaronson NK, et al. The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer. 2006;42(1):55\u201364. https:\/\/doi.org\/10.1016\/j.ejca.2005.06.022.","journal-title":"Eur J Cancer"},{"key":"3417_CR17","unstructured":"CDC (2018) CDC compilation of benzodiazepines, muscle relaxants, stimulants, zolpidem, and opioid analgesics with oral morphine milligram equivalent conversion factors, 2018 version. Atlanta, GA: US Department of Health and Human Services, National Center for Injury Prevention and Control, CDC,"},{"issue":"5","key":"3417_CR18","doi-asserted-by":"publisher","first-page":"E441","DOI":"10.36076\/ppj\/2019.22.E441","volume":"22","author":"D Sayed","year":"2019","unstructured":"Sayed D, Jacobs D, Sowder T, Haines D, Orr W. Spinal radiofrequency ablation combined with cement augmentation for painful spinal vertebral metastasis: a single-center prospective study. Pain Physician. 2019;22(5):E441\u20139.","journal-title":"Pain Physician"},{"issue":"2","key":"3417_CR19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3978\/j.issn.2224-5820.2014.04.06","volume":"3","author":"C Johnstone","year":"2014","unstructured":"Johnstone C, Lutz ST. External beam radiotherapy and bone metastases. Ann Palliat Med. 2014;3(2):114\u201322. https:\/\/doi.org\/10.3978\/j.issn.2224-5820.2014.04.06.","journal-title":"Ann Palliat Med"},{"issue":"10","key":"3417_CR20","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.clon.2006.09.007","volume":"18","author":"JP Agarawal","year":"2006","unstructured":"Agarawal JP, Swangsilpa T, van der Linden Y, Rades D, Jeremic B, Hoskin PJ. The role of external beam radiotherapy in the management of bone metastases. Clin Oncol (R Coll Radiol). 2006;18(10):747\u201360. https:\/\/doi.org\/10.1016\/j.clon.2006.09.007.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"3417_CR21","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.ijrobp.2019.06.382","volume":"105","author":"S Ryu","year":"2019","unstructured":"Ryu S, Deshmukh S, Timmerman RD, et al. radiosurgery compared to external beam radiotherapy for localized spine metastasis: Phase III results of NRG Oncology\/RTOG 0631. Int J Radiat Oncol Biol Phys. 2019;105(1):S2\u20133. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.06.382.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"3417_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ijrobp.2019.12.041","volume":"107","author":"S van de Ven","year":"2020","unstructured":"van de Ven S, van den Bongard D, Pielkenrood B, et al. Patient-reported outcomes of oligometastatic patients after conventional or stereotactic radiation therapy to bone metastases: an analysis of the PRESENT cohort. Int J Radiat Oncol Biol Phys. 2020;107(1):39\u201347. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.12.041.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"3417_CR23","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1470-2045(21)00196-0","volume":"22","author":"A Sahgal","year":"2021","unstructured":"Sahgal A, Myrehaug SD, Siva S, et al. Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2\/3 trial. Lancet Oncol. 2021;22(7):1023\u201333. https:\/\/doi.org\/10.1016\/S1470-2045(21)00196-0.","journal-title":"Lancet Oncol"},{"issue":"1","key":"3417_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11060-015-1813-2","volume":"124","author":"AN Wallace","year":"2015","unstructured":"Wallace AN, Greenwood TJ, Jennings JW. Radiofrequency ablation and vertebral augmentation for palliation of painful spinal metastases. J Neurooncol. 2015;124(1):111\u20138. https:\/\/doi.org\/10.1007\/s11060-015-1813-2.","journal-title":"J Neurooncol"},{"key":"3417_CR25","unstructured":"Brown HK, Healey JH (2001) SECTION 52.4 Metastatic Cancer to the Bone. Lippincott Williams & Wilkins, Philadephia"},{"key":"3417_CR26","doi-asserted-by":"publisher","unstructured":"Gerszten PC, Mendel E, Yamada Y (2009) Radiotherapy and radiosurgery for metastatic spine disease: what are the options, indications, and outcomes? Spine (Phila Pa 1976), 34(22 Suppl):S78\u201392. https:\/\/doi.org\/10.1097\/BRS.0b013e3181b8b6f5","DOI":"10.1097\/BRS.0b013e3181b8b6f5"},{"key":"3417_CR27","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2147\/CLEP.S85496","volume":"7","author":"RK Hernandez","year":"2015","unstructured":"Hernandez RK, Adhia A, Wade SW, et al. Prevalence of bone metastases and bone-targeting agent use among solid tumor patients in the United States. Clin Epidemiol. 2015;7:335\u201345. https:\/\/doi.org\/10.2147\/CLEP.S85496.","journal-title":"Clin Epidemiol"},{"issue":"3","key":"3417_CR28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.adro.2018.04.002","volume":"3","author":"N Mehta","year":"2018","unstructured":"Mehta N, Zavitsanos PJ, Moldovan K, et al. Local failure and vertebral body fracture risk using multifraction stereotactic body radiation therapy for spine metastases. Adv Radiat Oncol. 2018;3(3):245\u201351. https:\/\/doi.org\/10.1016\/j.adro.2018.04.002.","journal-title":"Adv Radiat Oncol"},{"issue":"30","key":"3417_CR29","doi-asserted-by":"publisher","first-page":"5075","DOI":"10.1200\/JCO.2008.19.3508","volume":"27","author":"PS Rose","year":"2009","unstructured":"Rose PS, Laufer I, Boland PJ, et al. Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases. J Clin Oncol. 2009;27(30):5075\u20139. https:\/\/doi.org\/10.1200\/JCO.2008.19.3508.","journal-title":"J Clin Oncol"},{"issue":"8","key":"3417_CR30","doi-asserted-by":"publisher","first-page":"e310","DOI":"10.1016\/S1470-2045(13)70101-3","volume":"14","author":"A Sahgal","year":"2013","unstructured":"Sahgal A, Whyne CM, Ma L, Larson DA, Fehlings MG. Vertebral compression fracture after stereotactic body radiotherapy for spinal metastases. Lancet Oncol. 2013;14(8):e310-320. https:\/\/doi.org\/10.1016\/S1470-2045(13)70101-3.","journal-title":"Lancet Oncol"},{"issue":"8","key":"3417_CR31","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1002\/cncr.22991","volume":"110","author":"F Saad","year":"2007","unstructured":"Saad F, Lipton A, Cook R, Chen YM, Smith M, Coleman R. Pathologic fractures correlate with reduced survival in patients with malignant bone disease. Cancer. 2007;110(8):1860\u20137. https:\/\/doi.org\/10.1002\/cncr.22991.","journal-title":"Cancer"},{"issue":"4","key":"3417_CR32","first-page":"317","volume":"17","author":"PR Anchala","year":"2014","unstructured":"Anchala PR, Irving WD, Hillen TJ, et al. Treatment of metastatic spinal lesions with a navigational bipolar radiofrequency ablation device: a multicenter retrospective study. Pain Physician. 2014;17(4):317\u201327.","journal-title":"Pain Physician"},{"issue":"3","key":"3417_CR33","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jvir.2007.09.016","volume":"19","author":"RT Hoffmann","year":"2008","unstructured":"Hoffmann RT, Jakobs TF, Trumm C, Weber C, Helmberger TK, Reiser MF. Radiofrequency ablation in combination with osteoplasty in the treatment of painful metastatic bone disease. J Vasc Interv Radiol. 2008;19(3):419\u201325. https:\/\/doi.org\/10.1016\/j.jvir.2007.09.016.","journal-title":"J Vasc Interv Radiol"},{"issue":"7","key":"3417_CR34","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.jvir.2009.03.035","volume":"20","author":"PL Munk","year":"2009","unstructured":"Munk PL, Rashid F, Heran MK, et al. Combined cementoplasty and radiofrequency ablation in the treatment of painful neoplastic lesions of bone. J Vasc Interv Radiol. 2009;20(7):903\u201311. https:\/\/doi.org\/10.1016\/j.jvir.2009.03.035.","journal-title":"J Vasc Interv Radiol"},{"issue":"5","key":"3417_CR35","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s00270-004-0208-0","volume":"28","author":"N Toyota","year":"2005","unstructured":"Toyota N, Naito A, Kakizawa H, et al. Radiofrequency ablation therapy combined with cementoplasty for painful bone metastases: initial experience. Cardiovasc Intervent Radiol. 2005;28(5):578\u201383. https:\/\/doi.org\/10.1007\/s00270-004-0208-0.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"11","key":"3417_CR36","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/j.jvir.2020.08.002","volume":"31","author":"TI Mehta","year":"2020","unstructured":"Mehta TI, Heiberger C, Kazi S, et al. Effectiveness of radiofrequency ablation in the treatment of painful osseous metastases: a correlation meta-analysis with machine learning cluster identification. J Vasc Interv Radiol. 2020;31(11):1753\u201362. https:\/\/doi.org\/10.1016\/j.jvir.2020.08.002.","journal-title":"J Vasc Interv Radiol"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-023-03417-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-023-03417-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-023-03417-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T15:05:50Z","timestamp":1683126350000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-023-03417-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,3]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["3417"],"URL":"http:\/\/dx.doi.org\/10.1007\/s00270-023-03417-x","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":["Cardiology and Cardiovascular Medicine","Radiology, Nuclear Medicine and imaging"],"published":{"date-parts":[[2023,4,3]]},"assertion":[{"value":"19 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JL is a paid consultant for Medtronic, serves on an Advisory Board, provides lectures\/teaching, and receives support for attending meetings. JL is also a consultant for Varian and provides lectures\/presentations for Sirtex, which also provides support to attend meetings. TH is a paid consultant for Medtronic and receives research funding from SPR Therapeutics. JM is a paid consultant and lecturer for Medtronic. NDT is a paid consultant, Advisory Board member, and lecturer for Medtronic. AV and PS receive personal fees from Medtronic. AG has patents planned, issued or pending from APRIOMED and receives royalties. NVdH is a paid consultant for Medtronic. SB is a paid consultant for Boston Scientific, Medtronic, and Terumo, and Varian. None of the other authors have identified a conflict of interest. None of the authors were paid for their involvement with this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human or Animal Participants"}},{"value":"Informed consent was obtained from all individual participants included in the study. For this type of study consent for publication is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}} |